Merrion Road

Orphan designation: Dabrafenib mesylate Treatment of glioma, 09/12/2020 Positive

Retrieved on: 
Monday, December 18, 2023
Glioma, Vomiting, Medicine, Eurostat, COMP, Skin cancer, Pressure, Brain, Safety, Radiation, Merrion Road, European Commission, Ageing, Disease, Headache, Civil service commission, Patient, European, Skull, Dabrafenib, Marketing, Lung cancer, Muscle weakness, Committee, Seizure, Melanoma, BRAF, Population, Nausea, Survival, Cancer, Diagnosis, Date rape drug, Growth, Regulation, Personality, EURORDIS, Knowledge, Tribhuvan University, Cell, Pharmaceutical industry, Medical device, Medical imaging, Vaccine

Orphan designation: Dabrafenib mesylate Treatment of glioma, 09/12/2020 Positive

Key Points: 


Orphan designation: Dabrafenib mesylate Treatment of glioma, 09/12/2020 Positive

I-RES completes acquisition of Tara View, Merrion Road, Dublin 4

Retrieved on: 
Monday, August 15, 2022
Trust, Industry, Legislation, Growth, Investment, Hospital, Elm Park, Group, Merrion Road, Dalata Hotel Group, City centre, IRES, Government, Schoolyard, Company, School, Acquisition, Real estate investment trust, The Group, COVID-19, Employment, Angelo Gordon, Euronext Dublin, VAT, Sales, Property management

I-RES completes acquisition of Tara View, Merrion Road, Dublin 4

Key Points: 
  • I-RES completes acquisition of Tara View, Merrion Road, Dublin 4
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • I-RES completes acquisition of Tara View, Merrion Road, Dublin 4
    Dublin | 15 August: Irish Residential Properties REIT plc ("I-RES" or the "Company") is pleased to announce it has completed the acquisition of 69 new residential homes at Tara View, Merrion Road, Dublin 4 (formerly known as Project Merrion).
  • Tara View is a prime waterfront development located adjacent to the Elm Park development (where the Company owns 194 apartments) in Dublin 4, Irelands premier residential address.
  • These excellent homes, many with excellent views across Dublin Bay and the Dublin mountains, will appeal to a range of residents.

Dalata Hotel Group PLC: Trading Update

Retrieved on: 
Wednesday, June 29, 2022
Department, Department of Children, Equality, Disability, Integration and Youth, DHG, Fallout of the 2009 Irish government budget, Disability, Dallata, EBITDA, Government, Sale, Central office, Main–Market Historic District, Trade, Republic of Ireland, Integration, Refugee, Clayton, London Stock Exchange, United Kingdom, Contract, Merrion Road, Central, RevPAR, Irish Residential Properties REIT, Group, DAL, Uncertainty, Tourism, Risk management, COVID-19

Dublin and London | 29 June 2022: Dalata Hotel Group plc ("Dalata" or "the Group"), the largest hotel operator in Ireland, with a growing presence in the United Kingdom and continental Europe, provides a trading update for the second quarter of 2022.

Key Points: 
  • Dublin and London | 29 June 2022: Dalata Hotel Group plc ("Dalata" or "the Group"), the largest hotel operator in Ireland, with a growing presence in the United Kingdom and continental Europe, provides a trading update for the second quarter of 2022.
  • Dalata announced in April that RevPAR [i] for the Group was 9% ahead of 2019 levels for the March/April period.
  • Dalata Hotel Group plc was founded in August 2007 and listed as a plc in March 2014.
  • Dalata successfully operate Irelands two largest hotel brands, the Clayton and the Maldron Hotels.